Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
about
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-BDNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara VaccinationOne Group's Historical Reflections on DNA Vaccine Development
P2860
Q41918753-EDBB690B-E1E2-4185-8492-CFE08376AD17Q47364595-9B3C877E-8B76-4225-9E54-3EB1F13BA8D7Q54263363-D6345C08-39EE-4169-9B94-B913003CA110Q55154648-597C73F6-5E75-4216-9F7B-20078EF86E39Q57009763-AACDE758-2670-46A9-8496-700148ABDE6FQ58711069-17F809A5-AA37-46EE-8AD2-E35D8A8DC9A2Q58731456-C213EB66-CB8D-42C3-A419-0511CBECAB55
P2860
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immunogenicity of a novel Clad ...... althy HIV-1 uninfected adults.
@en
type
label
Immunogenicity of a novel Clad ...... althy HIV-1 uninfected adults.
@en
prefLabel
Immunogenicity of a novel Clad ...... althy HIV-1 uninfected adults.
@en
P2093
P2860
P50
P921
P1433
P1476
Immunogenicity of a novel Clad ...... althy HIV-1 uninfected adults.
@en
P2093
Brittany J Sanchez
Christine M Hay
Georgia D Tomaras
HIV Vaccine Trials Network (HVTN) 094 Study Group
Harriet L Robinson
Kelly E Seaton
M Anthony Moody
Nicole A Grunenberg
Nicole Frahm
Paul A Goepfert
P2860
P304
P356
10.1371/JOURNAL.PONE.0179597
P407
P577
2017-07-20T00:00:00Z